Article contents
Acetylcholinesterase inhibitor donepezil in the treatment of cognitive deficit in schizophrenia. Subanalysis of the active branch from Czech extended double blind study
Published online by Cambridge University Press: 16 April 2020
Abstract
The article mentions the conclusions of most evidential works investigating donepezil in the treatment of cognitive deficit in schizophrenia. It focuses on an analysis of a sub-group of 20 patients receiving treatment of the donepezil in an extended Czech double-blind placebo controlled study.
- Type
- Short communication
- Information
- Copyright
- Copyright © Elsevier Masson SAS 2006
References
- 2
- Cited by
Comments
No Comments have been published for this article.